High Quality good supplier 69004-03-1 Toltrazuril in stock

The company has perfect enterprise management system from R&D to production, favorable R&D capability, and has established close cooperation relations with domestic well-known colleges and universities and scientific research institutions. Moreover, it has set up “Changzhou Engineering Technology Research Center of Biological Veterinary Drug” for chemical synthesis and R&D of biological fermentation technology. It has won titles including “Jintan City Intellectual Property Work Demonstration Enterprise”, “Jintan City Advanced Enterprise for Technological Progress”, “Jiangsu Province Private Science and Technology Enterprise”, and etc. Lingyun has developed several international advanced high-tech products dominated by toltrazuril, decoquinate, tulathromycin, and etc. Main products are toltrazuril, decoquinate, tulathromycin, ponazuril and other veterinary drugs. 

The company has complete quality control system and it has passed the ISO9000 and other quality system certifications. Our products are sold well in more than 20 countries and regions, and they are highly praised by clients at home and abroad. Adhering to enterprise spirit of "integrity and innovation" and R&D tenet of "green and health", we would like to cooperate with you for contributing to the cause of animal health!

Jiangsu Willing Bio-Tech Co., Ltd. is wholly-owned subsidiary of Jiangsu Lingyun Pharmaceutical Co., Ltd., engaging in the R&D, production and sales of marketing raw materials of veterinary drugs. It is situated in Huaian City, Jiangsu. Weiling successfully passed the GMP acceptance of Ministry of Agriculture in 2016.

We focus on animal health care products sales of more than 10 years, strong customer groups, and the German Bayer (five top ranked 155th in the world, the world's largest raw material suppliers ranking second, Germany's second-biggest chemical pharmaceutical enterprise, Germany's largest industrial group), the Swiss Novartis (market value column global 21st, pharmaceutical industry ranked third in the world, Switzerland's largest company, ranking at the forefront of the global OTC market), the United States ALPHARMA (the world's top 500, leading the registration, production and sales of global pharmaceutical and nutritional products), France VIRBAC (the world's top 500, The company has established strategic partnership with Nutrasweet (the world's top 500), Pfizer (the world's top 500, the world's largest pharmaceutical company, the first and second largest pharmaceutical company in the United States), and its sales network has involved various countries.